Case report: Obstructive jaundice caused by biliary cystadenoma

por Li, Yun-cheng, Shi, An-da, Li, Kang-shuai
Publicado 2023

Adjuvant therapies after curative treatments for hepatocellular carcinoma: Current status and prospects

por Zhu, Xiao-Dong, Li, Kang-Shuai, Sun, Hui-Chuan
Publicado 2020

Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis

por Li, Kang-Shuai, Guo, Sen, Chen, Yu-Xin, Zhang, Zong-Li
Publicado 2022

SMAD4 regulates the progression of cholangiocarcinoma by modulating the expression of STING1

por Shi, An‐da, Zhao, Li‐ming, Sheng, Guo‐li, Zhang, Ge‐ning, Tang, Yong‐chang, Li, Kang‐shuai, Zhang, Zong‐li
Publicado 2023

Physical activity improves outcomes of combined lenvatinib plus anti-PD-1 therapy in unresectable hepatocellular carcinoma: a retrospective study and mouse model

por Liu, Xue-Feng, Zhu, Xiao-Dong, Feng, Long-Hai, Li, Xiao-Long, Xu, Bin, Li, Kang-Shuai, Xiao, Nan, Lei, Ming, Sun, Hui-Chuan, Tang, Zhao-You
Publicado 2022

Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma

por Feng, Long-Hai, Sun, Hui-Chuan, Zhu, Xiao-Dong, Zhang, Shi-Zhe, Li, Xiao-Long, Li, Kang-Shuai, Liu, Xue-Feng, Lei, Ming, Li, Yan, Tang, Zhao-You
Publicado 2021

PFKFB3 blockade inhibits hepatocellular carcinoma growth by impairing DNA repair through AKT

por Shi, Wen-Kai, Zhu, Xiao-Dong, Wang, Cheng-Hao, Zhang, Yuan-Yuan, Cai, Hao, Li, Xiao-Long, Cao, Man-Qing, Zhang, Shi-Zhe, Li, Kang-Shuai, Sun, Hui-Chuan
Publicado 2018

NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma

por Li, Kang-Shuai, Zhu, Xiao-Dong, Liu, Hong-Da, Zhang, Shi-Zhe, Li, Xiao-Long, Xiao, Nan, Liu, Xue-Feng, Xu, Bin, Lei, Ming, Zhang, Yuan-Yuan, Shi, Wen-Kai, Cao, Man-Qing, Xu, Yun-Fei, Tang, Zhao-You, Sun, Hui-Chuan
Publicado 2020

Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers

por Li, Yun-cheng, Li, Kang-shuai, Liu, Zeng-li, Tang, Yong-chang, Hu, Xiao-Qiang, Li, Xing-yong, Shi, An-da, Zhao, Li-ming, Shu, Li-Zhuang, Lian, Shuo, Yan, Zhang-di, Huang, Shao-hui, Sheng, Guo-li, Song, Yan, Liu, Yun-jia, Huan, Fan, Zhang, Ming-hui, Zhang, Zong-li
Publicado 2022

miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a

por Cao, Man-Qing, You, A-Bin, Zhu, Xiao-Dong, Zhang, Wei, Zhang, Yuan-Yuan, Zhang, Shi-Zhe, Zhang, Ke-wei, Cai, Hao, Shi, Wen-Kai, Li, Xiao-Long, Li, Kang-Shuai, Gao, Dong-Mei, Ma, De-Ning, Ye, Bo-Gen, Wang, Cheng-Hao, Qin, Cheng-Dong, Sun, Hui-Chuan, Zhang, Ti, Tang, Zhao-You
Publicado 2018

Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a

por Cao, Man-Qing, You, A-Bin, Zhu, Xiao-Dong, Zhang, Wei, Zhang, Yuan-Yuan, Zhang, Shi-Zhe, Zhang, Kei-wei, Cai, Hao, Shi, Wen-Kai, Li, Xiao-Long, Li, Kang-Shuai, Gao, Dong-Mei, Ma, De-Ning, Ye, Bo-Gen, Wang, Cheng-Hao, Qin, Cheng-Dong, Sun, Hui-Chan, Zhang, Ti, Tang, Zhao-You
Publicado 2018